Yuanda Pharmaceutical (00512.HK) rose more than 6% in the intraday period. As of press release, it rose 4.94% to HK$4.25, with a turnover of HK$21.15,900.
港股异动 | 远大医药(00512.HK)盘中涨超6% 国产碳14同位素年底向市场供货 国产核药迎来新机遇
Changes in Hong Kong stocks | Yuanda Pharmaceutical (00512.HK) rose more than 6% in the intraday period, domestic carbon-14 isotopes to supply domestic nuclear drugs to the market at the end of the year ushered in new opportunities
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.